Mechanism-first reference language for catalog peptides. This dictionary automatically lists all compounds categorized as peptides.
Mechanism: Selective Lipolytic Fragment (hGH residue). Research Profile: Isolates the lipolytic sequence of the Growth Hormone molecule without the blood sugar or growth effects. Studies observe targeted adipose tissue breakdown (fat loss) and inhibition of new lipid storage in metabolic models.
Open DatasheetMechanism: Systemic/Local Tissue Repair Peptide. Research Profile: Renowned in literature for accelerated soft tissue recovery. Assays show rapid fibroblast migration to injured sites (tendons, ligaments, gut endothelium) and upregulation of growth hormone receptors in connective tissue.
Open DatasheetMechanism: Long-Acting GHRH Analog. Research Profile: Designed to create a sustained, pulsatile release of endogenous growth hormone. Literature correlates this with elevated IGF-1 plasma levels, nitrogen retention (muscle preservation), and enhanced protein synthesis rates in subjects.
Open DatasheetMechanism: Amylin Analog (Satiety Signal). Research Profile: A non-GLP-1 agent that targets the amylin receptor. Research suggests a potent synergistic effect when stacked with Semaglutide, pushing satiety signaling (fullness) beyond the ceiling of GLP-1 agonists alone.
Open DatasheetMechanism: Delta Sleep-Inducing Peptide. Research Profile: A neuromodulator that crosses the blood-brain barrier. Literature focuses on its ability to induce slow-wave (Delta) sleep architecture, regulate circadian rhythms, and modulate cortisol (stress) production in sleep-deprived models.
Open DatasheetMechanism: Telomerase Activator. Research Profile: Studied for its role in "biological age" reversal via telomere elongation. Markers include circadian rhythm restoration (sleep cycles) and antioxidant defense upregulation in aging models.
Open DatasheetMechanism: Copper-Binding Remodeling Peptide. Research Profile: Exhibits strong regenerative properties in skin and hair models. Data shows upregulation of collagen production, reduction of inflammatory cytokines, and enhanced dermal remodeling (tightening) in tissue samples.
Open DatasheetMechanism: Recombinant Somatropin. Research Profile: Identical to the human body's primary growth signal. Research confirms broad-spectrum effects including hyperplasia (new muscle cell creation), systemic lipolysis (fat oxidation), and rapid connective tissue turnover.
Open DatasheetMechanism: Long-Acting Insulin-like Growth Factor-1. Research Profile: An analog of human IGF-1 modified to resist binding proteins, extending active half-life to ~20-30 hours. Research highlights include potent hyperplasia (splitting of muscle cells) and enhanced nutrient shuttling into skeletal muscle tissue in vitro.
Open DatasheetMechanism: Selective Growth Secretagogue. Research Profile: The "cleanest" growth hormone output in class. Studies show it triggers a strong GH pulse without elevating cortisol (stress) or prolactin (water retention), making it the preferred reference standard for lean tissue research.
Open DatasheetMechanism: Alpha-MSH Fragment (Anti-Inflammatory). Research Profile: A C-terminal fragment of alpha-MSH. Unlike Melanotan, it has no tanning effect. Research isolates its potent anti-microbial and anti-inflammatory properties, specifically regarding gut mucosal healing and pathogen reduction in mast cell assays.
Open DatasheetMechanism: Mitochondrial "Exercise Mimetic." Research Profile: Acts directly on the mitochondria to regulate metabolism. Literature describes it as an "exercise mimetic," enhancing glucose uptake in muscle tissue and preventing insulin resistance even in high-fat diet models.
Open DatasheetMechanism: Dual Agonist (GLP-1 / Glucagon). Research Profile: Stronger than standard GLP-1s due to the addition of the Glucagon (GCGR) component. Research indicates this drives active energy expenditure (burning calories) alongside appetite suppression, resulting in faster lipid reduction metrics.
Open DatasheetMechanism: Non-Selective Melanocortin Agonist. Research Profile: Targets MC1 and MC4 receptors. Primary outcomes in subjects include rapid melanogenesis (pigmentation) independent of UV exposure and significant stimulation of hypothalamic arousal pathways (arousal).
Open DatasheetMechanism: Cellular Energy Coenzyme. Research Profile: Essential for ATP production. Research focuses on restoring cellular energy levels, activating Sirtuin "longevity" pathways, and repairing DNA damage in fatigued or aged cellular models.
Open DatasheetMechanism: Central Nervous System Arousal Agent. Research Profile: A metabolite of Melanotan II that isolates the arousal-enhancing effects. Studies show it acts directly on the nervous system to trigger physiological arousal, independent of the vascular system (blood flow).
Open DatasheetMechanism: Triple Agonist (GLP-1 / GIP / Glucagon). Research Profile: The current "Gold Standard" for metabolic velocity. By activating all three metabolic receptors, it demonstrates maximum lipid oxidation (fat loss) and efficacy rates significantly higher than dual-agonist comparators in clinical datasets.
Open DatasheetMechanism: Mitochondrial Protector. Research Profile: Targets the inner mitochondrial membrane. Research shows it restores efficiency in fatigued mitochondria, reduces oxidative stress, and improves endurance markers in cardiac and skeletal muscle tissue.
Open DatasheetMechanism: Anxiolytic Neuropeptide. Research Profile: Modulates the GABA system to regulate stress response. Subjects exhibit reduced anxiety markers and improved mental stability without the sedation or addiction potential of traditional benzos.
Open DatasheetMechanism: GLP-1 Receptor Agonist. Research Profile: The baseline reference for weight management. Mechanism involves delaying gastric emptying (feeling full) and regulating insulin. Consistent data shows reliable, linear reduction in subject mass over time.
Open DatasheetMechanism: Cognitive Enhancer (BDNF). Research Profile: Stimulates Brain-Derived Neurotrophic Factor. Research highlights include sharpened cognitive processing, faster reaction times, and neuroprotection during ischemic stress (low oxygen).
Open DatasheetMechanism: Liver-Focused Dual Agonist. Research Profile: A Glucagon-heavy agonist. Research emphasizes its ability to strip lipids from the liver (hepatic fat reduction) while providing the standard weight reduction benefits of the GLP-1 class.
Open DatasheetMechanism: Systemic Mobility Peptide. Research Profile: A synthetic version of Thymosin Beta-4. Known for systemic cellular migration, helping actin (muscle fiber) regenerate and reducing inflammation across the entire subject, improving flexibility and recovery speed.
Open DatasheetMechanism: GHRH Analog (Visceral Specificity). Research Profile: A stabilized Growth Hormone Releasing Hormone analog. Clinical datasets distinguish this compound by its specific correlation with visceral adipose tissue (VAT) reduction (deep abdominal fat) and improved lipid profiles in metabolic subjects.
Open DatasheetMechanism: Dual Agonist (GIP / GLP-1). Research Profile: Superior to single-agonists. The addition of the GIP receptor signaling improves adipose tissue handling and reduces nausea side-effects, allowing for higher dosing and greater total mass reduction in studies.
Open DatasheetIndexed peptide entries: 25.